Product image of Midazolam Accord (Midazolam) supplied by GNH India

Midazolam Accord

Active Ingredient:
Midazolam
Origin:
EU

Midazolam Accord (Midazolam)

Midazolam, the active ingredient in Midazolam Accord, is a benzodiazepine presented as a sterile injectable solution for intramuscular, intravenous, or rectal use. It provides rapid sedation, anxiolysis, and anticonvulsant effects for patients requiring procedural sedation, pre‑anesthetic preparation, or emergency seizure control. It is indicated for use in adult and pediatric patients under professional supervision.

GNH India supplies Midazolam Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable logistics to pharmacies, clinics, and procurement teams across multiple continents.

Manufacturer / TM Owner

Accord Healthcare B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Midazolam acts on the central nervous system by enhancing GABA‑mediated inhibition, making it useful in several acute care settings.

  • Procedural sedation: provides rapid, controllable sedation for diagnostic or therapeutic procedures.
  • Pre‑anesthetic medication: reduces anxiety and induces amnesia before induction of anesthesia.
  • Status epilepticus: terminates ongoing seizures when administered promptly.
  • Acute anxiety: offers short‑term relief of severe anxiety episodes in monitored settings.

How It Works

  • Midazolam binds to a distinct site on the γ‑aminobutyric acid type‑A (GABA‑A) receptor complex, acting as a positive allosteric modulator. This interaction increases the frequency of chloride channel opening events in response to GABA, leading to hyperpolarization of neuronal membranes and enhanced inhibitory neurotransmission. The resulting effect depresses central nervous system activity, producing sedation, anxiolysis, muscle relaxation, and anticonvulsant properties.

Side Effects

Midazolam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Drowsiness
  • Dizziness
  • Amnesia
  • Nausea

Serious or Rare Side Effects

  • Severe respiratory depression
  • Hypotension or shock
  • Paradoxical agitation

Precautions & Warnings

When using Midazolam, clinicians should observe several precautionary measures to ensure patient safety.

  • Assess respiratory function: monitor oxygen saturation and ventilation continuously.
  • Monitor cardiovascular status: watch for hypotension and arrhythmias.
  • Use with caution in the elderly: increased sensitivity may require dose adjustment.
  • Avoid abrupt discontinuation: tapering reduces risk of withdrawal or rebound anxiety.
  • Adjust dose in hepatic impairment: reduced clearance may prolong effects.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Midazolam can interact with other medications, altering its sedative effect or increasing toxicity.

Major Interactions (Avoid)

  • Opioids: combined CNS depression can cause profound respiratory suppression.
  • Other benzodiazepines: additive sedative effects increase risk of oversedation.
  • Central nervous system depressants (e.g., barbiturates, antihistamines): may lead to severe respiratory depression.

Moderate Interactions (Monitor Closely)

  • Antifungal azoles (e.g., ketoconazole): inhibit metabolism, raising midazolam plasma levels.
  • Antidepressants (e.g., SSRIs, SNRIs): may enhance sedation and require dose adjustment.

Frequently Asked Questions

Midazolam Accord is a benzodiazepine formulation used for procedural sedation, pre‑anesthetic medication, treatment of status epilepticus, and short‑term relief of acute anxiety in monitored clinical settings.

Midazolam enhances the activity of the neurotransmitter GABA at the GABA‑A receptor, increasing chloride ion influx and hyperpolarising neurons. This potentiates inhibitory signalling, leading to sedation, anxiolysis, muscle relaxation and anticonvulsant effects.

The dose of Midazolam Accord is individualized by the prescribing clinician based on the patient’s age, weight, clinical condition, route of administration and response. No fixed regimen is provided here.

Safety data for Midazolam in pregnancy and lactation are limited. It is generally classified as a drug to be used only if the potential benefit justifies any potential risk to the fetus or infant, and should be prescribed with caution.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Midazolam has a faster onset and shorter duration of action than diazepam, making it preferable for brief procedures or emergency seizure control. Both belong to the benzodiazepine class, but their pharmacokinetic profiles differ, influencing choice based on clinical need.

Midazolam Accord should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and physical damage. Follow standard aseptic handling procedures for injectable solutions.

Midazolam Accord is supplied as a sterile injectable solution and can be administered intramuscularly, intravenously, or rectally, depending on the clinical indication and the prescriber’s judgment.

The most serious risks include severe respiratory depression, profound hypotension or shock, and paradoxical reactions such as agitation or aggression. These events require immediate medical intervention and close monitoring.

Midazolam should be avoided in patients with known hypersensitivity to benzodiazepines, severe respiratory insufficiency, acute narrow‑angle glaucoma, or in those taking other potent CNS depressants without appropriate monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Midazolam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT